Use of radiotelemetry to evaluate respiratory depression produced by chronic methadone administration

European Journal of Pharmacology

Volumn 484, Issue 2-3, 2004, Pages 303-310

  Lewanowitsch, Tanya ^a   White, Jason M ^a,b   Irvine, Rodney J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Drug & Alcohol Services South Australia   (Australia)

Author keywords

Methadone; Naloxone methiodide; Radiotelemetry; Respiratory depression

Indexed keywords

17 METHYLNALOXONE; METHADONE; NALOXONE; OPIATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BRADYCARDIA; BREATHING RATE; CHRONIC TOXICITY; CLINICAL FEATURE; CONTROLLED STUDY; DRUG TOLERANCE; EVALUATION; HEART RATE; HYPOCAPNIA; LOCOMOTION; MALE; NIGHT; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATION DEPRESSION; TELEMETRY;

EID: 1642464804     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.11.025     Document Type: Article

References (47)

1. Amalric M., Koob G.F. Low doses of methylnaloxonium in the nucleus accumbens antagonize hyperactivity induced by heroin in the rat. Pharmacol. Biochem. Behav. 23:1985;411-415.
2. Baraban S.C., Stornetta R.L., Guyenet P.G. Respiratory control of sympathetic nerve activity during naloxone-precipitated morphine withdrawal in rats. J. Pharmacol. Exp. Ther. 265:1993;89-95.
3. Barron B.A. Cardiac opioids. Proc. Soc. Exp. Biol. Med. 224:2000;1-7.
4. Borg L., Kreek M.J. Pharmacology of opiates. Tarter R.E., Ammerman R.T., Ott P.J. Handbook of Substance Abuse: Neurobehavioural Pharmacology. 1998;331-341 Plenum Press, New York.
5. Brandt M.R., France C.P. Chronic L-alpha-acetylmethadol (LAAM) in rhesus monkeys: tolerance and cross-tolerance to the antinociceptive, ventilatory, and rate-decreasing effects of opioids. J. Pharmacol. Exp. Ther. 294:2000;168-178.
6. Cabot P.J., Dodd P.R., Cramond T., Smith M.T. Characterization of non-conventional opioid binding sites in rat and human lung. Eur. J. Pharmacol. 268:1994;247-255.
7. Cairns A., Roberts I.S., Benbow E.W. Characteristics of fatal methadone overdose in Manchester, 1985-94. Br. Med. J. 313:1996;264-265.
8. Chan R., Irvine R., White J. Cardiovascular changes during morphine administration and spontaneous withdrawal in the rat. Eur. J. Pharmacol. 368:1999;25-33.
9. Cruz S.L., Rodriguez-Manzo G. Gender differences in the cardiovascular responses to morphine and naloxone in spinal rats. Eur. J. Pharmacol. 397:2000;121-128.
10. Czapla M.A., Gozal D., Alea O.A., Beckerman R.C., Zadina J.E. Differential cardiorespiratory effects of endomorphin 1, endomorphin 2, DAMGO, and morphine. Am. J. Respir. Crit. Care Med. 162:2000;994-999.
11. Darke S., Ross J., Hall W. Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose. Addiction. 91:1996;405-411.
12. Dyer K.R., Foster D.J., White J.M., Somogyi A.A., Menelaou A., Bochner F. Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships. Clin. Pharmacol. Ther. 65:1999;685-694.
13. Ebert B., Andersen S., Krogsgaard-Larsen P. Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci. Lett. 187:1995;165-168.
14. Gorman A.L., Elliott K.J., Inturrisi C.E. The D- and L-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci. Lett. 223:1997;5-8.
15. Gritz E.R., Shiffman S.M., Jarvik M.E., Haber J., Dymond A.M., Coger R., Charuvastra V., Schlesinger J. Physiological and psychological effects of methadone in man. Arch. Gen. Psychiatry. 32:1975;237-242.
16. Karch S.B., Stephens B.G. Toxicology and pathology of deaths related to methadone: retrospective review. West. J. Med. 172:2000;11-14.
17. Kokka N., Elliot H.W., Way L.E. Some effects of morphine on respiration and metabolism of rats. J. Pharmacol. Exp. Ther. 148:1965;386-392.
18. Kramer K., Grimbegen J., Brockway B., Brockway B., Voss H.P. Circadian respiratory rate rhythms in freely moving small laboratory animals using radio telemetry. Lab. Anim. 28:1999;38-41.
19. Lenton S.R., Hargreaves K.M. Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal? Overdose. Med. J. Aust. 173:2000;260-263.
20. Lewanowitsch T., Irvine R.J. Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal. Eur. J. Pharmacol. 445:2002;61-67.
21. Lewanowitsch T., Irvine R.J. Naloxone and its quaternary derivative, naloxone methiodide, have differing affinities for mu, delta, and kappa opioid receptors in mouse brain homogenates. Brain Res. 964:2003;302-305.
22. Martin W.R. Naloxone. Ann. Intern. Med. 85:1976;765-768.
23. Martin W.R., Jasinski D.R. Physiological parameters of morphine dependence in man - tolerance, early abstinence, protracted abstinence. J. Psychiatr. Res. 7:1969;9-17.
24. McCormick G.Y., White W.J., Zagon I.S., Lang C.M. Effects of diazepam on arterial blood gas concentrations and pH of adult rats acutely and chronically exposed to methadone. J. Pharmacol. Exp. Ther. 230:1984;353-359.
25. McGilliard K.L., Takemori A.E. Alterations in the antagonism by naloxone of morphine-induced respiratory depression and analgesia after morphine pretreatment. J. Pharmacol. Exp. Ther. 207:1978;884-891.
26. McGilliard K.L., Takemori A.E. Antagonism by naloxone of narcotic-induced respiratory depression and analgesia. J. Pharmacol. Exp. Ther. 207:1978;494-503.
27. McGregor C., Darke S., Ali R., Christie P. Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions. Addiction. 93:1998;701-711.
28. McGregor C., Ali R., Lokan R., Christie P., Darke S. Accidental fatalities among heroin users in South Australia, 1994-1997: toxicological findings and circumstances of death. Addict. Res. Theory. 10:2002;335-346.
29. McQuay H. Opioids in pain management. Lancet. 353:1999;2229-2232.
30. Milanes M.V., Martinez M.D., Gonzalez-Cuello A., Laorden M.L. Evidence for a peripheral mechanism in cardiac opioid withdrawal. Naunyn-Schmiedeberg's Arch. Pharmacol. 364:2001;193-198.
31. Misra A.L., Pontani R.B., Vadlamani N.L. Intravenous kinetics and metabolism of [15,16-3H]naltrexonium methiodide in the rat. J. Pharm. Pharmacol. 39:1987;225-227.
32. Neal R.C., Olsen G.D. The effects of methadone on respiration and ventilation in Pygmy goats. J. Pharmacol. Exp. Ther. 215:1980;45-52.
33. Paronis C.A., Woods J.H. Ventilation in morphine-maintained rhesus monkeys: II. Tolerance to the antinociceptive but not the ventilatory effects of morphine. J. Pharmacol. Exp. Ther. 282:1997;355-362.
34. Roerig S.C., Fujimoto J.M., Lange D.G. Development of tolerance to respiratory depression in morphine- and etorphine-pellet-implanted mice. Brain Res. 400:1987;278-284.
35. Salvato C., Aretini G., Serraglia D., Terrazzani G., Debetto P., Giusti P., Chinellato A. Opioid prescription for terminally ill outpatients in a district of northern Italy: a retrospective survey. Pharmacol. Res. 48:2003;75-82.
36. Santiago T.V., Pugliese A.C., Edelman N.H. Control of breathing during methadone addiction. Am. J. Med. 62:1977;347-354.
37. Schlenker E.H., Inamdar S.R. Effects of naloxone on oxygen consumption and ventilation in awake golden Syrian hamsters. Physiol. Behav. 57:1995;655-658.
38. Schulteis G., Markou A., Gold L.H., Stinus L., Koob G.F. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J. Pharmacol. Exp. Ther. 271:1994;1391-1398.
39. Schultz J.J., Hsu A.K., Gross G.J. Ischemic preconditioning is mediated by a peripheral opioid receptor mechanism in the intact rat heart. J. Mol. Cell. Cardiol. 29:1997;1355-1362.
40. Seal K.H., Downing M., Kral A.H., Singleton-Banks S., Hammond J.P., Lorvick J., Ciccarone D., Edlin B.R. Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco bay area. J. Urban Health. 80:2003;291-301.
41. Trewin D. Australian Social Trends 2001. 2001;71-75 Australia Bureau of Statistics, Canberra.
42. Vaccarino A.L., Kastin A.J. Endogenous opioids: 2000. Peptides. 22:2001;2257-2328.
43. Van den Hoogen R.H., Colpaert F.C. Respiratory effects of morphine in awake unrestrained rats. J. Pharmacol. Exp. Ther. 237:1986;252-259.
44. White W.J., Zagon I.S. Acute and chronic methadone exposure in adult rats: studies on arterial blood gas concentrations and pH. J. Pharmacol. Exp. Ther. 209:1979;451-455.
45. Williamson P.A., Foreman K.J., White J.M., Anderson G. Methadone-related overdose deaths in South Australia, 1984-1994. How safe is methadone prescribing? Med. J. Aust. 166:1997;302-305.
46. Wolff K. Characterization of methadone overdose: clinical considerations and the scientific evidence. Ther. Drug Monit. 24:2002;457-470.
47. Yeadon M., Kitchen I. A new method for determination of in vivo pA2 using infusions of naloxone to steady-state blood concentrations. J. Pharmacol. Methods. 20:1988;29-37.